Literature DB >> 27764574

Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates.

Michel de Jesús Aceves-Sánchez1, Mario Alberto Flores-Valdez1.   

Abstract

Entities:  

Keywords:  mice; preclinical studies; tuberculosis; vaccines

Mesh：

Substances：

Year:  2016        PMID： 27764574      PMCID： PMC5360148          DOI： 10.1080/21645515.2016.1248010

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  11 in total

Review 1.  Disease model: pulmonary tuberculosis.

Authors:  D N McMurray
Journal:  Trends Mol Med       Date:  2001-03       Impact factor: 11.951

Review 2.  Animal models of tuberculosis for vaccine development.

Authors:  U D Gupta; V M Katoch
Journal:  Indian J Med Res       Date:  2009-01       Impact factor: 2.375

3.  PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Int J Antimicrob Agents       Date:  2014-09-16       Impact factor: 5.283

4.  Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination.

Authors:  E Medina; R J North
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

5.  Mouse and guinea pig models for testing new tuberculosis vaccines.

Authors:  Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2005-01-22       Impact factor: 3.131

6.  A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation.

Authors:  Andreas Kupz; Ulrike Zedler; Manuela Stäber; Stefan H E Kaufmann
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  A humanized mouse model of tuberculosis.

Authors:  Veronica E Calderon; Gustavo Valbuena; Yenny Goez; Barbara M Judy; Matthew B Huante; Putri Sutjita; R Katie Johnston; D Mark Estes; Robert L Hunter; Jeffrey K Actor; Jeffrey D Cirillo; Janice J Endsley
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

8.  Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype.

Authors:  Clare M Smith; Megan K Proulx; Andrew J Olive; Dominick Laddy; Bibhuti B Mishra; Caitlin Moss; Nuria Martinez Gutierrez; Michelle M Bellerose; Palmira Barreira-Silva; Jia Yao Phuah; Richard E Baker; Samuel M Behar; Hardy Kornfeld; Thomas G Evans; Gillian Beamer; Christopher M Sassetti
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

9.  Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection.

Authors:  Lingjun Zhan; Jun Tang; Shuzhu Lin; Yanfeng Xu; Yuhuan Xu; Chuan Qin
Journal:  Front Microbiol       Date:  2016-01-08       Impact factor: 5.640

Review 10.  Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.

Authors:  Igor Kramnik; Gillian Beamer
Journal:  Semin Immunopathol       Date:  2015-11-05       Impact factor: 9.623
View more
  1 in total

1.  Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878.

Authors:  Bhagwati Khatri; James Keeble; Belinda Dagg; Daryan A Kaveh; Philip J Hogarth; Mei Mei Ho
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.